Mycotic pseudoaneurysm of the left circumflex coronary artery: A fatal complication following drug-eluting stent implantation

Catheterization and Cardiovascular Interventions

Volumn 69, Issue 4, 2007, Pages 508-512

  Le, Mimi Q ^a   Narins, Craig R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Coronary pseudoaneurysm; Coronary stent infection; Drug eluting stent

Indexed keywords

PACLITAXEL; RAPAMYCIN; VANCOMYCIN;

AGED; ARTICLE; BARE METAL STENT; CASE REPORT; CELL PROLIFERATION; CORONARY ARTERY ANEURYSM; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY STENT; FALSE ANEURYSM; HUMAN; IMMUNOMODULATION; IMPLANTATION; INFECTION COMPLICATION; MALE; MYCOTIC PSEUDOANEURYSM; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; STAPHYLOCOCCUS AUREUS;

AGED; ANEURYSM, FALSE; ANEURYSM, INFECTED; BLOOD VESSEL PROSTHESIS IMPLANTATION; CARDIOVASCULAR AGENTS; CELL PROLIFERATION; CORONARY RESTENOSIS; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PACLITAXEL; PROSTHESIS-RELATED INFECTIONS; SIROLIMUS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STENTS;

EID: 33847686836     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21014     Document Type: Article

References (12)

1. Leroy O, Martin E, Prat A, Decoulx E, Georges H, Guilley J, Beuscart C, Beaucaire G. Fatal infection of coronary stent implantation. Cathet Cardiovasc Diagn 1996;39:168-170.
2. Bouchart F, Dubar A, Bessou JP, Redonnet M, Berland J, Mouton-Schleifer D, Haas-Hubscher C, Soyer R. Pseudomonas aeruginosa coronary stent infection. Ann Thorac Surg 1997;64:1810-1813.
3. Liu JC, Cziperle DJ, Kleinman B, Loeb H. Coronary abscess: A complication of stenting. Catheter Cardiovasc Interv 2003;58:69-71.
4. Singh H, Singh C, Aggarwal N, Dugal JS, Kumar A, Luthra M. Mycotic aneurysm of left anterior descending artery after sirolimus-eluting stent implantation: A case report. Catheter Cardiovasc Interv 2005;65:282-285.
5. Alfonso F, Moreno R, Vergas J. Fatal infection after rapamycin eluting coronary stent implantation. Heart 2005;91:e51-e52.
6. Marcu CB, Balf DV, Donohue TJ. Post-infectious psuedoaneurysm after coronary angioplasty using durg eluting stents. Heart Lung Circ 2005;14:85-86.
7. Samore MH, Wessolossky MA, Lewis SM, Shubrooks SJ, Karchmer AW. Frequency, risk factors, and outcome for bacteremia after percutaneous transluminal coronary angioplasty. Am J Cardiol 1997;79:873-877.
8. Shea KW, Schwartz RK, Gambino AT, Marzo KP, Cunha BA. Bacteremia associated with percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1995;36:5-9.
9. Paget DS, Bukhari RH, Zayyat EJ, Lohr JM, Roberts WH, Welling RE. Infectibility of endovascular stents following antibiotic prophylaxis or after arterial wall incorporation. Am J Surg 1999;178:219-224.
10. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Terstein PS, Jaeger JL, Kuntz JL;the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-1323.
11. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
12. Costa MA, Simon DI. Molecular basis of restenosis and drug eluting stents. Circulation 2005;111:2257-2273.